Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
08/12/2009 | EP1141239B1 Improved methods for insertion of nucleic acids into circular vectors |
08/12/2009 | EP1030675B1 Treatment of hematologic disorders |
08/12/2009 | CN101506369A Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV in insect cells |
08/12/2009 | CN101506360A Pullulanase variants with increased productivity |
08/12/2009 | CN101506356A Manufacturing method of activated lymphocytes for immunotherapy |
08/12/2009 | CN101506355A Multipotential expanded mesenchymal precursor cell progeny (MEMP) and uses thereof |
08/12/2009 | CN101506354A Method of production of transgenic avian using embryonic stem cells |
08/12/2009 | CN101506353A Processing procedure for peripheral blood stem cells |
08/12/2009 | CN101506352A Identification and selection of stem cells being committed to differentiate to a specific type for obtaining a homogeneous population of stem cells |
08/12/2009 | CN101506351A Methods for prediction and prognosis of cancer, and monitoring cancer therapy |
08/12/2009 | CN101506350A Methods for rejuvenating cells in vitro and in vivo |
08/12/2009 | CN101506349A A method to manufacture effective bioreactor |
08/12/2009 | CN101506345A Microchip and method of cell sorting |
08/12/2009 | CN101506237A Anti-C5aR antibodies with improved properties |
08/12/2009 | CN101506236A Monoclonal antibodies against amyloid beta protein and uses thereof |
08/12/2009 | CN101505791A Diagnosis and treatment of cancer using anti-desmoglein-3 antibody |
08/12/2009 | CN101505786A A novel peptide involved in energy homeostasis |
08/12/2009 | CN101505780A Treatment of development-related disorders |
08/12/2009 | CN101504407A Sex-specific insemination of mammals with low number of sperm cells |
08/12/2009 | CN101504406A Sex-specific insemination of mammals with low number of sperm cells |
08/12/2009 | CN101504405A Sex-specific insemination of mammals with low number of sperm cells |
08/12/2009 | CN101503693A Halimodendron halodendron ERF transcription factor cDNA sequence, expression vector and use thereof |
08/12/2009 | CN101503691A Plant epidermal hair specific expression promoter F1F1 and use thereof |
08/12/2009 | CN101503690A Method for promoting plant seed augmentation and cotton fibre growth by using RDL1 gene |
08/12/2009 | CN101503678A Malt oligosaccharide based mycose synthetase, coding gene and use |
08/12/2009 | CN101503675A Oophoroma multidrug resistance cell strain established by etoposide induction |
08/12/2009 | CN101503674A Cervical cancer multidrug resistance cell strain established by cisplatin induction |
08/12/2009 | CN101503673A Cervical cancer multidrug resistance cell strain established by etoposide induction |
08/12/2009 | CN101503672A Composition of cytokine and use thereof |
08/12/2009 | CN101503671A Method for improving Fraxinus mandshurica somatic embryo development synchronization |
08/12/2009 | CN101503468A Protein related to pollen germination and/or pollen tube growth, coding gene and use thereof |
08/12/2009 | CN101503467A Plant stress tolerance related transcription factor GmNAC20, coding gene and use thereof |
08/12/2009 | CN101503466A Birdsfoot trefoil root flower type and inflorescence structure regulating gene, coding protein and use thereof |
08/12/2009 | CN101503464A Novel Bt protein Cry30Fa1, coding gene thereof and use |
08/12/2009 | CN101503463A Novel Bt protein Cry53Ab1, coding gene thereof and use |
08/12/2009 | CN101502450A Sex-specific insemination of mammals with low number of sperm cells |
08/12/2009 | CN101502238A Micro-propagation method for Populus hybride |
08/12/2009 | CN101502237A Micro-propagation method for white birch with purple leaf |
08/12/2009 | CN100526463C Methods for making Apo-2 ligand using divalent metal ions |
08/12/2009 | CN100526460C Transgenic ungulates having reduced prion protein activity and uses thereof |
08/12/2009 | CN100526457C 3-phosphoglycerate dehydrogenase variants whose inhibition by L-serine is reduced, and genes encoding them |
08/12/2009 | CN100526456C Method for transplanting consubstantial cell nucleus |
08/12/2009 | CN100526455C Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability |
08/12/2009 | CN100526454C Magnetic nano cell automatic sorting device and uses thereof |
08/12/2009 | CN100526453C Cell collection method after laser microdissection |
08/12/2009 | CN100526305C Compound for promoting neurocyte growth |
08/11/2009 | US7572962 Maize hybrid variety X5H332 |
08/11/2009 | US7572961 Maize hybrid variety 32N89 |
08/11/2009 | US7572960 Soybean variety D4637114 |
08/11/2009 | US7572958 Soybean variety D4361423 |
08/11/2009 | US7572956 Soybean cultivar 6139105 |
08/11/2009 | US7572954 Melon having high percent soluble solids and improved firmness |
08/11/2009 | US7572953 Plants with delayed flowering |
08/11/2009 | US7572952 Genetic construct with a coding sequence for a gamma -tocopherol methyltransferase operably connected to a plant promoter not natively associated with the coding sequence which when expressed in a plant results in an alteration in the ratio of alpha- gamma tocopherol |
08/11/2009 | US7572906 for drug screening treatments for human immunodeficiency virus (HIV), cancer; gene therapy; long terminal repeat sequences; genetic engineering |
08/11/2009 | US7572900 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
08/11/2009 | US7572899 Compositions and methods for increasing bone mineralization |
08/11/2009 | US7572889 Bt toxin receptors from lepidopteran insects |
08/11/2009 | US7572888 Fusion protein comprising arrestin and green fluorescent protein for use in identifying ligands for g-protein coupled receptors |
08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
08/11/2009 | US7572882 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
08/11/2009 | US7572763 Controlling cell differentiation; muscular disorders |
08/11/2009 | US7572638 Automated system and method for processing multiple liquid-based specimens |
08/11/2009 | US7572635 Method for agrobacterium transformation for dihaploid corn plants |
08/11/2009 | US7572632 Dry powder cells and cell culture reagents and methods of production thereof |
08/11/2009 | US7572631 Activation and expansion of T cells |
08/11/2009 | US7572630 Method for differentiating primate embryonic stem cell into vascular cell |
08/11/2009 | US7572628 Eukaryotic layered vector initiation systems |
08/11/2009 | US7572623 Supplying a suspension of cells in a treatment volume, which includes two electrodes in fluid contact with the suspension, applying a time varying bipolar electric potential across the electrode creating an electric field to porate the cell(s) |
08/11/2009 | US7572619 Using immortalized trangenic cell to express antihemophilic factor and blood coagulation factor IX for treatment of blood disorders |
08/11/2009 | US7572617 Thermostable ribonuclease H obtained from Archeoglobus profundus |
08/11/2009 | US7572616 Combating disorders affecting mitochondrial oxidative phosphorylation system by allotopic expression of the cyanide-insensitive alternative oxidase (AOX) in human cells; polynucleotide obtained from Mollusca, Nematoda and Chordata; metabolic, cardiovascular, genetic, and nervous system disorders |
08/11/2009 | US7572602 Nucleic acid encoding endolysin fusion protein |
08/11/2009 | US7572587 CryET29 (delta-endotoxin with activity against fleas and beetles); insecticidal activity against not only insects of the order Coleoptera, but also against fleas, and in particular larvae of the cat flea, Ctenocephalides felis |
08/11/2009 | US7572580 Promoter variants of the alpha-7 nicotinic acetylcholine receptor |
08/11/2009 | US7572456 Comprising three VH complementary determining regions (CDRs) and three VL CDRs; plasmids; hybridomas |
08/11/2009 | US7572447 Methods and compositions for selective modulation of vascularization |
08/11/2009 | US7572444 Binding proteins specific for human matriptase |
08/11/2009 | US7572438 Mutant having uracil phosphoribosyl transferase activity |
08/11/2009 | CA2391370C Method of cryopreserving selected sperm cells |
08/11/2009 | CA2348732C Human h37 proteins and cdnas encoding the same |
08/11/2009 | CA2342300C Mutant luciferase having increased thermostability |
08/11/2009 | CA2328133C Factors affecting tumor necrosis factor receptor releasing enzyme activity |
08/11/2009 | CA2289283C Metastasis models using green fluorescent protein (gfp) as a marker |
08/11/2009 | CA2271248C Use of a notch ligand in immunotherapy |
08/11/2009 | CA2241572C Apo-2 ligand |
08/11/2009 | CA2129648C Device for cell culture treatment |
08/10/2009 | WO2009122962A1 Method of producing transformed plant by using agrobacterium strain |
08/06/2009 | WO2009097559A1 Extracellular matrix compositions |
08/06/2009 | WO2009097421A1 Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells |
08/06/2009 | WO2009097411A1 Synthetic surfaces for culturing stem cell derived cardiomyocytes |
08/06/2009 | WO2009097140A1 Methods for off -the -shelf tumor immunotherapy using allogeneic t-cell precursors |
08/06/2009 | WO2009097135A1 Methods and compositions for treating carcinoma stem cells |
08/06/2009 | WO2009097119A2 Identification of cd8+ t cells that are cd161hi and/or il18r(alpha)hi and have rapid drug efflux capacity |
08/06/2009 | WO2009097014A2 Therapeutic kinase modulators |
08/06/2009 | WO2009096902A1 Method of differentiating stem cells |
08/06/2009 | WO2009096780A1 Method for manufacturing a tissue-engineered construct |
08/06/2009 | WO2009096614A1 Method of manufacturing induced pluripotent stem cell originated from somatic cell |
08/06/2009 | WO2009096445A1 Nerve trunk cell propagation accelerator |
08/06/2009 | WO2009096162A1 Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody |